Moderate Evidence (L3-L4)

Candidates with preliminary evidence that require further validation


Criteria

Level Definition Clinical meaning
L3 Observational studies / large case series Preliminary support; needs further validation
L4 Preclinical / mechanistic studies Theoretical support; far from clinical use

L3 (45 drugs)

Drug Indications Link
Acetaminophen 1 View report
Alprazolam 3 View report
Amikacin 10 View report
Aminophylline 10 View report
Amiodarone 10 View report
Amoxicillin 8 View report
Atenolol 9 View report
Budesonide 10 View report
Bumetanide 1 View report
Calcipotriol 10 View report
Captopril 4 View report
Carbamazepine 10 View report
Cefazolin 8 View report
Chlorpromazine 10 View report
Clobetasol 1 View report
Clonazepam 3 View report
Cytarabine 9 View report
Efavirenz 3 View report
Ephedrine 3 View report
Ertapenem 2 View report
Famotidine 10 View report
Fenofibrate 7 View report
Levetiracetam 10 View report
Levonorgestrel 6 View report
Levothyroxine 10 View report
Meropenem 10 View report
Methylergometrine 10 View report
Methylprednisolone 10 View report
Miconazole 1 View report
Moxifloxacin 10 View report
Norethisterone 1 View report
Olodaterol 2 View report
Omeprazole 2 View report
Oxcarbazepine 10 View report
Rifampicin 10 View report
Ropivacaine 4 View report
Sofosbuvir 8 View report
Sulfacetamide 10 View report
Tamoxifen 10 View report
Tenofovir 3 View report
Terazosin 10 View report
Thiamine 4 View report
Thiopental 10 View report
Vancomycin 10 View report
Vinblastine 10 View report

L4 (70 drugs)

Drug Indications Link
Abacavir 3 View report
Allopurinol 10 View report
Ampicillin 10 View report
Atropine 2 View report
BENZOYL PEROXIDE   View report
Bacitracin 10 View report
Bedaquiline 10 View report
Benzoyl Peroxide 4 View report
Bicalutamide 10 View report
Bisoprolol 5 View report
Brinzolamide 1 View report
Bromazepam 1 View report
Carvedilol 5 View report
Cefoxitin 10 View report
Chlorambucil 8 View report
Chloroquine 4 View report
Ciprofloxacin 10 View report
Clofazimine 3 View report
Cyproterone Acetate 10 View report
Dacarbazine 1 View report
Daclatasvir 10 View report
Deferasirox 5 View report
Deferiprone 9 View report
Diethylcarbamazine 2 View report
Digoxin 6 View report
Dipyridamole 10 View report
Dolutegravir 3 View report
Doxycycline 10 View report
Emtricitabine 3 View report
Enoxaparin 1 View report
Entecavir 10 View report
Epirubicin 7 View report
Erythromycin 5 View report
Ethambutol 5 View report
Etonogestrel 5 View report
Etoposide 10 View report
Filgrastim 10 View report
Flupentixol 9 View report
Imatinib 10 View report
Imiglucerase 5 View report
Interferon Alfa 10 View report
Isoniazid 1 View report
Lamivudine 5 View report
Lansoprazole 2 View report
Levofloxacin 10 View report
Losartan 8 View report
Lynestrenol 5 View report
Mannitol 10 View report
Metoclopramide 5 View report
Micafungin 1 View report
Nalidixic Acid 4 View report
Nevirapine 3 View report
Nitrofurantoin 10 View report
Norepinephrine 3 View report
Oxacillin 4 View report
Physostigmine 1 View report
Ribavirin 10 View report
Rifaximin 6 View report
Ritonavir 3 View report
Rivastigmine 1 View report
Rosuvastatin 10 View report
Streptomycin 10 View report
Sumatriptan 1 View report
Tetracycline 4 View report
Theophylline 7 View report
Tobramycin 10 View report
Tranexamic Acid 1 View report
Valsartan 7 View report
Vasopressin 2 View report
Warfarin 7 View report

Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.

Reviewed by: 藥提醒科技有限公司 (yao.care)

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only.

This site uses Just the Docs, a documentation theme for Jekyll.